Seems likely it was the Prostagene acquisition, as
Post# of 148147
(Total Views: 586)
Posted On: 08/30/2023 1:35:48 PM
Seems likely it was the Prostagene acquisition, as that happened in FY 2019.
Unless our legal team is suing for an improper valuation of the acquisition, and there is no indication of that as far as I know, I don't know that anybody connected with us would have uncovered the impropriety. It would be a big leap anyway from WA auditing us and the associated entity's valuation of the acquisition to an implication there was collusion between the auditors and Pestell to pump the price.
Seems likely that either an internal check by one of the audit firms or an inspection by an independent body picked up the conflict of interest.
Unless our legal team is suing for an improper valuation of the acquisition, and there is no indication of that as far as I know, I don't know that anybody connected with us would have uncovered the impropriety. It would be a big leap anyway from WA auditing us and the associated entity's valuation of the acquisition to an implication there was collusion between the auditors and Pestell to pump the price.
Seems likely that either an internal check by one of the audit firms or an inspection by an independent body picked up the conflict of interest.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼